At baseline, the acute patient cohort who subsequently resolve their infection have significantly lower levels of inhibitory CD158B expressing NK cells suggesting that diminished inhibitory responses upon initial encounter with HCV may contribute to protection against HCV and that these responses may in part be genetically controlled [43]. This evidence concerns the gene KIR2DL3 and infection.